These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8209501)
1. [The principles of administering drug and non-drug treatment methods in peptic ulcer]. Perederiĭ VG; Bychkova NG; Petrov AV; Seliuk MN; Dogotar' VB; Iurchenko ES; Tkach SM; Shvets GL; Vysotiuk LA; Marusanich BN Lik Sprava; 1993; (5-6):58-61. PubMed ID: 8209501 [TBL] [Abstract][Full Text] [Related]
2. [Drug and non-drug immunocorrection in peptic ulcer]. Petrov AV; Bychkova NG; Perederiĭ VG; Dogotar' VB; Vysotiuk LA Lik Sprava; 1993 Apr; (4):100-2. PubMed ID: 8209427 [TBL] [Abstract][Full Text] [Related]
3. [The immunological aspects of the antibacterial therapy of peptic ulcer patients]. Bychkova NG; Petrov AV; Perederiĭ VG; Iurchenko ES Lik Sprava; 1993; (10-12):79-81. PubMed ID: 8030316 [TBL] [Abstract][Full Text] [Related]
4. [The effect of superhigh-frequency electromagnetic radiation on the course of Helicobacter pylori-associated peptic ulcer]. Starodub IeM; Samohal's'ka OIe; Markiv IM; Luchanko PI Lik Sprava; 1994 Jan; (1):85-7. PubMed ID: 8067031 [TBL] [Abstract][Full Text] [Related]
5. [An SHF electromagnetic field (460 MHz) combined with the preparation Tribimol in treating duodenal peptic ulcer associated with Helicobacter pylori]. Filimonov RM; Korolev IuN; Konicheva ER Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (1):23-5. PubMed ID: 9560998 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy. Cherian PT; Cherian S; Singh P Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640 [TBL] [Abstract][Full Text] [Related]
7. [The drug prophylaxis of peptic ulcer exacerbations]. Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253 [TBL] [Abstract][Full Text] [Related]
8. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview]. Leodolter A; Peitz U; Malfertheiner P Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994 [TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560 [TBL] [Abstract][Full Text] [Related]
10. [Combined therapy of duodenal ulcer associated with Helicobacter pylori with electromagnetic decimeter waves and colloidal bismuth subcitrate]. Filimonov RM; Korolev IuN; Kochineva ER Vopr Kurortol Fizioter Lech Fiz Kult; 1993; (6):19-22. PubMed ID: 8154113 [No Abstract] [Full Text] [Related]
11. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. Park KN; Hahm JS; Kim HJ Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924 [TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841 [TBL] [Abstract][Full Text] [Related]
13. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies. Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277 [TBL] [Abstract][Full Text] [Related]
15. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan. Tsuji S; Kawano S J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786 [No Abstract] [Full Text] [Related]
16. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI. Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153 [TBL] [Abstract][Full Text] [Related]
17. Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication. Pohle T; Hilker E; Domschke W Z Gastroenterol; 1997 Jul; 35(7):563-5. PubMed ID: 9273989 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease. Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725 [TBL] [Abstract][Full Text] [Related]
19. [The treatment characteristics of patients with peptic ulcer infected with Helicobacter pylori]. Kharchenko NV Lik Sprava; 1999 Mar; (2):70-4. PubMed ID: 10424047 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population. Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]